Evidence map›Paper›PMID 17526781›Full record

ArticleApplied and environmental microbiology2007

"Mark the gene": a method for nondestructive introduction of marker sequences inside the gene frame of transgenes.

Yuki Morono, Wataru Kitagawa, Nobutada Kimura, Naohiro Noda, Kazunori Nakamura, Yoichi Kamagata

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Applied and environmental microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuki MoronoInstitute for Biological Resources and Functions, National Institute of Advanced Industrial Science and Technology, Ibaraki, Japan.
Wataru Kitagawa
Nobutada Kimura
Naohiro Noda
Kazunori Nakamura
Yoichi Kamagata
National Institute of Advanced Industrial Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A specific marking and detection technique is a fundamental requirement for the safer use of genetically modified (GM) organisms. Here we propose a simple and effective method for directly marking functional transgenes in GM organisms. For that purpose, we introduced nucleotide substitutions (NS), based on the degeneracy of codons as markers (NS markers), into the bphC (2,3-dihydroxybiphenyl dioxygenase) and tomA3 (toluene-ortho-monooxygenase) gene frames using a PCR-based method. No change was observed in the enzyme activity of translated proteins, and alignments with homologous genes showed the uniqueness of the NS markers. Furthermore, we constructed tomA3 variations harboring NS markers in different positions. Although the translational products were identical, the constructed variation genes could be distinguished through their marker patterns by multiplex PCR, showing that NS markers could serve as product-specific tags for identifying individual GM organisms. This direct method of marking the functional transgene provides a simple, low-risk, and robust marking method without causing the gene functions to deteriorate.

Indexed as

Genetic MarkersTransgenesAmino Acid SequenceBacteriological TechniquesCodonDioxygenasesEscherichia coliGene TargetingGenetic TechniquesGenetic VariationMixed Function OxygenasesMolecular Sequence DataPolymerase Chain ReactionRecombination, Genetic2,3-dihydroxybiphenyl oxygenaseCodonDioxygenasesGenetic MarkersMixed Function Oxygenasestoluene ortho-monooxygenase

Identifiers

PMID17526781
PMCPMC1951010
OpenAlexW2130192200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.